Search Results - "Clemons M"

Physician "out of office" alert: does it work?

Authors: Clemons, M. Joy, A. A. Hilton, J. et al.

Source: Current Oncology. Jun2017, Vol. 24 Issue 3, pe177-e179. 4p. 2 Charts.

Oncologist heal thyself: hallmarks of happiness.

Authors: Jacobs, C. Clemons, M. Joy, A. A.

Source: Current Oncology. Dec2015, Vol. 22 Issue 6, pe415-e418. 4p. 1 Chart.

Publishing clinical research: ten pearls for oncology trainees and junior oncologists.

Authors: Mazzarello, S. Clemons, M. Jacobs, C. et al.

Source: Current Oncology. Feb2015, Vol. 22 Issue 1, pe1-e5. 5p. 1 Chart, 1 Graph.

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art.

Authors: Clemons, M. Gelmon, K. A. Pritchard, K. I. et al.

Source: Current Oncology. Oct2012, Vol. 19 Issue 5, p259-268. 10p. 1 Diagram, 4 Charts, 1 Graph.

Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy.

Authors: Lee, G. Clemons, M. Cho, J. et al.

Source: Current Oncology. Jun2012, Vol. 19 Issue 3, pe211-e215. 5p. 2 Color Photographs.

Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians.

Authors: Heisey, R. Clemons, M. Granek, L. et al.

Source: Current Oncology. Oct2011, Vol. 18 Issue 5, pe227-e237. 11p. 4 Charts.

O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts.

Authors: Clemons, M. Kelly, J. Watson, A. J. et al.

Source: British Journal of Cancer. 11/14/2005, Vol. 93 Issue 10, p1152-1156. 5p. 1 Chart, 5 Graphs.

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.

Authors: Clemons, M. Fergusson, D. Simos, D. et al.

Source: Annals of Oncology. Jul2020, Vol. 31 Issue 7, p951-957. 7p. 1 Diagram, 3 Charts.

Third-party online surveys--science, selling, or sugging?

Authors: Mazzarello, S. Clemons, M. Graham, I. D. et al.

Source: Current Oncology. Jun2015, Vol. 22 Issue 3, p182-183. 2p. 1 Chart.

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.

Authors: Mar Fan HG Clemons M Xu W et al.

Source: Supportive Care in Cancer. Jun2008, Vol. 16 Issue 6, p577-583. 7p.

Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model.

Authors: Dranitsaris G Clemons M Verma S et al.

Source: Lancet Oncology. Nov2005, Vol. 6 Issue 11, p856-863. 8p.

Should All Breast Cancer Patients with Symptomatic Bone Metastases be Treated with Bisphosphonates? The Case in Support^☆☆This debate was presented at the Tenth Annual Conference on ‘The Science and Art of Pain and Symptom Management’ held in Toronto, Canada on 14–15 November, 2003. Your views are welcomed in a letter to the Editor for publication in the correspondence section of the Journal.

Authors: Clemons, M.¹ mark.clemons@sw.ca

Source: Clinical Oncology. Apr2004, Vol. 16 Issue 2, p108. 4p.

Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?

Authors: Kuchuk, I. Clemons, M. Addison, C.

Source: Current Oncology. Oct2012, Vol. 19 Issue 5, pe303-e304. 2p.

Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours.

Authors: Clemons, M J Bibby, M C El Teraifi, H et al.

Source: British Journal of Cancer. 6/5/2002, Vol. 86 Issue 11, p1797-1802. 6p.

Mechanisms of disease. Estrogen and the risk of breast cancer.

Authors: Clemons M Goss P Epstein FH

Source: New England Journal of Medicine. 01/25/2001, Vol. 344 Issue 4, p276-285. 10p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Comparative effectiveness of interventions for cancer treatment–related cognitive impairment in adult cancer survivors: protocol for a systematic review.

Authors: Wolfe, D. M. Hamel, C. Rice, D. et al.

Source: Systematic Reviews. 8/5/2024, Vol. 13 Issue 1, p1-11. 11p.

Extending neoadjuvant care through multi-disciplinary collaboration: proceedings from the fourth annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer.

Authors: Boileau, J. F. Simmons, C. Clemons, M. et al.

Source: Current Oncology. Apr2012, Vol. 19 Issue 2, p106-114. 9p.

Phase II trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

Authors: Young, S. D. Lafrenie, R. M. Clemons, M. J.

Source: Current Oncology. Apr2012, Vol. 19 Issue 2, pe75-e83. 9p.